Streetbeat News

Stock Prices

LSF

Laird Superfood (AMEX:LSF) reported Q4 earnings, beating estimates with an EPS of $0.0 against an expected -$0.23, and revenue up $230k YOY. This follows a pattern of beating EPS estimates in previous quarters, with share price increases observed post-earnings.

Portfolio Pulse from Benzinga Insights

March 12, 2024 | 8:40 pm

BIRD

Allbirds shares are trading lower due to worse-than-expected Q4 GAAP EPS results.

Portfolio Pulse from Benzinga Newsdesk

March 12, 2024 | 8:39 pm

GE

GEHC

GE HealthCare Technologies has initiated a secondary offering of 13 million shares of its common stock. The shares are being sold by Morgan Stanley Bank, N.A., an affiliate of Morgan Stanley & Co. LLC, which acquired the shares through a debt-for-equity exchange with General Electric Company (GE). GE HealthCare will not receive any proceeds from this offering.

Portfolio Pulse from Benzinga Newsdesk

March 12, 2024 | 8:39 pm

AIRE

ReAlpha Tech shares are trading lower following the company's EPS report for the eight months ended December 31, 2023.

Portfolio Pulse from Benzinga Newsdesk

March 12, 2024 | 8:39 pm

ATER

Aterian (NASDAQ:ATER) reported Q4 2023 earnings with a smaller loss per share of $(0.10) compared to the $(0.13) estimate, and sales of $32.754M exceeding the $29.337M estimate. This represents a significant improvement in losses per share from the previous year but a decrease in sales.

Portfolio Pulse from Benzinga Newsdesk

March 12, 2024 | 8:38 pm

TNON

Tenon Medical's stock price increased following the announcement of their Q4 GAAP EPS results, which exceeded expectations.

Portfolio Pulse from Benzinga Newsdesk

March 12, 2024 | 8:37 pm

MINM

Minim's stock price increased following the announcement of a definitive merger agreement with e2Companies. This strategic move could potentially enhance Minim's market position and financial performance.

Portfolio Pulse from Benzinga Newsdesk

March 12, 2024 | 8:36 pm

NCNA

NuCana's stock price increased following the grant of U.S. Patent #11925658 for phosphoramidate derivatives used in cancer treatment, particularly where patients show resistance.

Portfolio Pulse from Benzinga Newsdesk

March 12, 2024 | 8:35 pm

VERI

Veritone (NASDAQ:VERI) reported Q4 earnings with an EPS of $-0.16, missing estimates by -7%, and a revenue decrease of $9.69 million from the previous year. This follows a pattern of missed EPS estimates in previous quarters, leading to a significant share price drop.

Portfolio Pulse from Benzinga Insights

March 12, 2024 | 8:35 pm

IGIC

Intl General Insurance (NASDAQ:IGIC) reported Q4 earnings with an EPS of $0.65, missing estimates by -8.0% against an expected $0.71. Revenue increased by $17.90 million from the previous year. Despite past quarters showing varied performance, this quarter's miss and the provided guidance of $0.65 EPS for Q4 2023 could influence investor sentiment.

Portfolio Pulse from Benzinga Insights

March 12, 2024 | 8:35 pm